CordenPharma is pleased to announce the completion of a new highly potent API laboratory in its Boulder, Colorado facility.
CordenPharma, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), is a full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Drug Products, and associated Packaging Services. Through a growing network of cGMP facilities across Europe and the US organized under four Technology Platforms – Peptides, Lipids & Carbohydrates, Injectables, Highly Potent & Oncology, and Small Molecules – CordenPharma experts translate complex processes and projects at any stage of development into high-value products.
For more information about CordenPharma, CordenPharma Media Contacts
North America
Abby Thompson
abby.thompson@cordenpharma.com
Europe & Asia
Eva Schaub
eva.schaub@cordenpharma.com